Skip to content
My WebMD Sign In, Sign Up
Dr Davis
 
avatar
jc3737 responded:
Here is a study Dr Davis published yrs ago.(from Pubmed)I posted this some years ago on this site but was wondering how Heretic eveluated the results.

Am J Ther. 2009 Jul-Aug;16(4):326-32. Effect of a combined therapeutic approach of intensive lipid management, omega-3 fatty acid supplementation, and increased serum 25 (OH) vitamin D on coronary calcium scores in asymptomatic adults. Davis W , Rockway S , Kwasny M . SourceMilwaukee Heart Scan, Milwaukee, WI, USA. heartprotection@aol.com
AbstractThe impact of intensive lipid management, omega-3 fatty acid, and vitamin D3 supplementation on atherosclerotic plaque was assessed through serial computed tomography coronary calcium scoring (CCS). Low-density lipoprotein cholesterol reduction with statin therapy has not been shown to reduce or slow progression of serial CCS in several recent studies, casting doubt on the usefulness of this approach for tracking atherosclerotic progression. In an open-label study, 45 male and female subjects with CCS of > or = 50 without symptoms of heart disease were treated with statin therapy, niacin, and omega-3 fatty acid supplementation to achieve low-density lipoprotein cholesterol and triglycerides < or = 60 mg/dL; high-density lipoprotein > or = 60 mg/dL; and vitamin D3 supplementation to achieve serum levels of > or = 50 ng/mL 25(OH) vitamin D, in addition to diet advice. Lipid profiles of subjects were significantly changed as follows: total cholesterol -24%, low-density lipoprotein -41%; triglycerides -42%, high-density lipoprotein 19%, and mean serum 25(OH) vitamin D levels 83%. After a mean of 18 months, 20 subjects experienced decrease in CCS with mean change of -14.5% (range 0% to -64%); 22 subjects experienced no change or slow annual rate of CCS increase of 12% (range 1%-29%). Only 3 subjects experienced annual CCS progression exceeding 29% (44%-71%). Despite wide variation in response, substantial reduction of CCS was achieved in 44% of subjects and slowed plaque growth in 49% of the subjects applying a broad treatment program
 
 
avatar
heretk replied to jc3737's response:
Do you have the full text?
 
avatar
jc3737 replied to heretk's response:
I don't.I found some peer reviewed studies Dr Davis did (on pub med),but it looks like the results are not as dramatic as he advertises but then neither are Dr Esselstyn's when you look at the actual study.I was hoping you could take an anlytical look at both peer reviewed studies and make an unbiased comparison.
 
avatar
dteresa replied to jc3737's response:
jc, the text you posted says losing weight causes a drastic reduction in crp. Is there any way that they isolated wheat as causing high crp and removal of wheat without weight loss as lowering crp? Both low carb and high carb and everywhere in between show excellent results with weight loss in improving several risk factors.

Dolores
 
avatar
jc3737 replied to dteresa's response:
I don't know....I suspect the main element might be to eat foods that tame inflammation and I suspect that would be plant based.

I have a blood test Dec 17 and I'm having fasting insulin as well as CRP tested....(if my doc can get the insurance to OK it)

My diet now is one almond,steamed vegetables,green leaf lettuce,beans,flax seed, and baked potatoes.I have two large baked potatoes at every meal so they make up the bulk of my calories.These tests should tell me how well the diet is working to keep down inflammation and insulin level.I'll post the results 4-5 days after the test.


Spotlight: Member Stories

My name is Ashley, I'm 20 years old. (5'6, 159 lbs). My interest in nutrition/living healthier started when at the age of 53 my father passed ...More

Helpful Tips

Zeal for Life
I couldn't find my old post so I'm not sure what happened to it. I have back problems, panic issues and anxiety disorder since childhood. ... More
Was this Helpful?
5 of 5 found this helpful

Related News

There was an error with this newsfeed

Report Problems With Your Medications to the FDA

FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.